Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Benchmarking network propagation methods for disease gene identification.

Picart-Armada S, Barrett SJ, Willé DR, Perera-Lluna A, Gutteridge A, Dessailly BH.

PLoS Comput Biol. 2019 Sep 3;15(9):e1007276. doi: 10.1371/journal.pcbi.1007276. eCollection 2019 Sep.


Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich.

Iorio F, Garcia-Alonso L, Brammeld JS, Martincorena I, Wille DR, McDermott U, Saez-Rodriguez J.

Sci Rep. 2018 Apr 30;8(1):6713. doi: 10.1038/s41598-018-25076-6.


The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.

Ripley TL, Sanchez-Roige S, Bullmore ET, Mugnaini M, Maltby K, Miller SR, Wille DR, Nathan P, Stephens DN.

Psychopharmacology (Berl). 2015 Sep;232(18):3431-41. doi: 10.1007/s00213-015-3995-x. Epub 2015 Jul 5.


Identification of BDNF sensitive electrophysiological markers of synaptic activity and their structural correlates in healthy subjects using a genetic approach utilizing the functional BDNF Val66Met polymorphism.

Soltész F, Suckling J, Lawrence P, Tait R, Ooi C, Bentley G, Dodds CM, Miller SR, Wille DR, Byrne M, McHugh SM, Bellgrove MA, Croft RJ, Lu B, Bullmore ET, Nathan PJ.

PLoS One. 2014 Apr 23;9(4):e95558. doi: 10.1371/journal.pone.0095558. eCollection 2014.


Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism.

Giuliano C, Robbins TW, Wille DR, Bullmore ET, Everitt BJ.

Psychopharmacology (Berl). 2013 May;227(1):137-47. doi: 10.1007/s00213-012-2949-9. Epub 2013 Jan 9.


Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro.

Marjanović N, Bosnar M, Michielin F, Willé DR, Anić-Milić T, Culić O, Popović-Grle S, Bogdan M, Parnham MJ, Eraković Haber V.

Pharmacol Res. 2011 May;63(5):389-97. doi: 10.1016/j.phrs.2011.02.001. Epub 2011 Feb 17.


Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, Brittain C, Rujescu D, Giegling I, Turck CW, Holsboer F, Bullmore ET, Middleton L, Merlo-Pich E, Alexander RC, Muglia P.

PLoS One. 2010 Feb 11;5(2):e9166. doi: 10.1371/journal.pone.0009166.


Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.

Cutler P, Akuffo EL, Bodnar WM, Briggs DM, Davis JB, Debouck CM, Fox SM, Gibson RA, Gormley DA, Holbrook JD, Hunter AJ, Kinsey EE, Prinjha R, Richardson JC, Roses AD, Smith MA, Tsokanas N, Willé DR, Wu W, Yates JW, Gloger IS.

Proteomics Clin Appl. 2008 Apr;2(4):467-77. doi: 10.1002/prca.200780101. Epub 2008 Mar 7.


Serum proteomic analysis during nicotine self-administration, extinction and relapse in rats.

Cecconi D, Tessari M, Willé DR, Zoli M, Domenici E, Righetti PG, Carboni L.

Electrophoresis. 2008 Apr;29(7):1525-33. doi: 10.1002/elps.200700388.


Supplemental Content

Loading ...
Support Center